Skip to main content

Table 1 Demographics and Baseline Disease Characteristics for Patients Who Completed or Discontinued the Study

From: Application of a disease-specific mapping function to estimate utility gains with effective treatment of schizophrenia

Parameter Patients Who Completed the Study (n = 474) Patients Who Discontinued (n = 251) P value Between Groups*
Age, y (mean ± SE) 43.7 ± 0.7 39.3 ± 0.9 <0.0001
Sex    0.730
   Female, n (%) 162 (34.2) 89 (35.5)  
   Male, n (%) 312 (65.8) 162 (64.5)  
Race    0.502
   Caucasian, n (%) 440 (92.8) 231 (92.0)  
   Black, n (%) 8 (1.7) 8 (3.2)  
   Asian, n (%) 6 (1.3) 5 (2.0)  
   Hispanic, n (%) 4 (0.8) 2 (0.8)  
   Other, n (%) 16 (3.4) 5 (2.0)  
Diagnosis    0.650
   Schizophrenia, n (%) 400 (84.4) 215 (85.7)  
   Schizoaffective disorder, n (%) 74 (15.6) 36 (14.3)  
  1. SE indicates standard error. *Chi-square test.